Michael J. Rybak, PharmD, professor in the Department of Pharmacy Practice, has received an award notification from the National Institutes of Health. The grant totals $429,658 over a two-year period with $190,000 awarded in the first year. Ryback is the principal investigator on the R21 "Impact of Daptomycin Dose Exposure on Enterococci and Characterization of Resista."

According to the U.S. Department of Health & Human Services website, "The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development."

The Eugene Applebaum College of Pharmacy and Health Sciences, one of the founding colleges of Wayne State University, is committed to advancing the health and well-being of society through the preparation of highly skilled health care practitioners, and through research to improve health care practices and treatment from urban to global levels.

Wayne State University is one of the nation's pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit http://www.research.wayne.edu.

Contact: Kathleen J. Karas, APR
Phone: 313-577-2312
Email: kkaras@wayne.edu